Aptahem AB
Biotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Oversikt
- 0
- Ansatte
- -1 SEK
- Omsetning
- 2014
- Grunnlagt
Nøkkelbeslutningstakere
Mikael Lindstam
CEO
Beskrivelse
Aptahem is a specialized biotechnology company focused on developing novel RNA-based pharmaceuticals. Their primary mission is to create disruptive treatments for acute, life-threatening inflammatory diseases, such as sepsis. The company's lead drug candidate, Apta-1, is currently progressing throug...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556970578201
Beslutningstakere
1 kontakter i FunnelfeedrMikael Lindstam
CEO
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Oblique Therapeutics AB (publ)
10–19 ansatteInnovative biotech developing breakthrough antibodies using the AbiProt platform.
Modus Therapeutics Holding AB
1–4 ansatteSwedish biotech developing sevuparin for severe inflammatory conditions.
Sangair AB
3 ansatteDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Ribocure Pharmaceuticals AB
20–49 ansatteClinical stage biotech developing cutting-edge RNA therapeutics for rare diseases.
IONLACE AB
9 ansatteRewriting medicine timelines using AI and modular protein design.
Utforsk mer
Spørsmål om Aptahem AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo